T1	Participants 126 158	Patients With Metabolic Syndrome
T3	Participants 482 514	patients with metabolic syndrome
T4	Participants 854 923	patients with metabolic syndrome in MARINE (n=204) and ANCHOR (n=645)
T2	Participants 355 427	patients with metabolic syndrome, with and without stable statin therapy
T5	Participants 1847 1996	patients with metabolic syndrome and high (≥200 and <500 mg/dL) or very high (≥500 and ≤2000 mg/dL) TG levels, with or without stable statin therapy.
